Product Name
Cartilage Intermediate Layer Protein (CILP), Polyclonal Antibody
Full Product Name
Polyclonal Antibody to Cartilage Intermediate Layer Protein (CILP)
Product Gene Name
anti-CILP antibody
[Similar Products]
Matching Pairs
Unconjugated Antibody: Cartilage Intermediate Layer Protein (CILP) (MBS2015469)
Immunogen: Cartilage Intermediate Layer Protein (CILP) (MBS2018653)
Matching Pairs
Unconjugated Antibody: Cartilage Intermediate Layer Protein (CILP) (MBS2015469)
APC-CY7 Conjugated Antibody: Cartilage Intermediate Layer Protein (CILP) (MBS2065260)
Matching Pairs
Unconjugated Antibody: Cartilage Intermediate Layer Protein (CILP) (MBS2015469)
PE Conjugated Antibody: Cartilage Intermediate Layer Protein (CILP) (MBS2065261)
Matching Pairs
Unconjugated Antibody: Cartilage Intermediate Layer Protein (CILP) (MBS2015469)
APC Conjugated Antibody: Cartilage Intermediate Layer Protein (CILP) (MBS2065262)
Matching Pairs
Unconjugated Antibody: Cartilage Intermediate Layer Protein (CILP) (MBS2015469)
Cy3 Conjugated Antibody: Cartilage Intermediate Layer Protein (CILP) (MBS2065263)
Matching Pairs
Unconjugated Antibody: Cartilage Intermediate Layer Protein (CILP) (MBS2015469)
FITC Conjugated Antibody: Cartilage Intermediate Layer Protein (CILP) (MBS2065264)
Matching Pairs
Unconjugated Antibody: Cartilage Intermediate Layer Protein (CILP) (MBS2015469)
HRP Conjugated Antibody: Cartilage Intermediate Layer Protein (CILP) (MBS2065265)
Matching Pairs
Unconjugated Antibody: Cartilage Intermediate Layer Protein (CILP) (MBS2015469)
APC-CY7 Conjugated Secondary Antibody: Immunoglobulin G (MBS2090675)
Matching Pairs
Unconjugated Antibody: Cartilage Intermediate Layer Protein (CILP) (MBS2015469)
Unconjugated Secondary Antibody: Immunoglobulin G (MBS2090678)
Matching Pairs
Unconjugated Antibody: Cartilage Intermediate Layer Protein (CILP) (MBS2015469)
Biotin Conjugated Antibody: Cartilage Intermediate Layer Protein (CILP) (MBS2094460)
Research Use Only
For Research Use Only. Not for use in diagnostic procedures.
Immunogen Sequence
Antigen: The target protein is fused with two N-terminal Tags, His-tag and T7-tag and its sequence is listed below.
MGSSHHHHHH SSGLVPRGSH MASMTGGQQM GRGSEF- PSKSFYR QNGEPFTGKV KASVTFLDPR NISTATAAQS DLNFINDEGD TFPLRTYGMF SVDFRDEATS ESLNAGKVKV HLDSTQVKMP EHVPAMKLWS LNPDTGLWEE EGDFKFESQR RNKREERTFL VGNMEIRERR LFNLDVPESR RCFIKVRTYR SERFLPSEQI QGVVVSVINL EPRTGFSSNP RAWGRFDSVI TGPNGACLPA FCDDQSPDAY SVYVLASLSG EELEAVESSP KFNPNAIGVP
3D Structure
ModBase 3D Structure for Q66K08
Specificity
The antibody is a rabbit polyclonal antibody raised against CILP. It has been selected for its ability to recognize CILP in immunohistochemical staining andwestern blotting.
Purity/Purification
Affinity Chromatography
Form/Format
Supplied as solution form in PBS, pH7.4, containing 0.02% NaN3,50% glycerol.
Concentration
200ug/ml (lot specific)
Immunogen
Recombinant CILP (Pro604~His864) expressed in E.coli.
Conjugated Antibody
The APC conjugated antibody version of this item is also available as catalog #MBS2065262
Preparation and Storage
Store at 4 degree C for frequent use. Stored at -20 degree C to -80 degree C in a manual defrost freezer for one year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
ISO Certification
Manufactured in an ISO 9001:2008 and ISO 13485:2003 Certified Laboratory.
Supply Chain Verification
Manufactured in a lab with traceable raw materials. Bulk orders can typically be prepared to the customera??s specifications, please inquire.
Other Notes
Small volumes of anti-CILP antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Applications Tested/Suitable for anti-CILP antibody
Immunocytochemistry (ICC), Immunohistochemistry (IHC) - Formalin/Paraffin, ELISA (EIA), Western Blot (WB)
Application Notes for anti-CILP antibody
Western blotting: 1:100-400
Immunocytochemistry in formalin fixed cells: 1:100-500
Immunohistochemistry in formalin fixed frozen section: 1:100-500
Immunohistochemistry in paraffin section: 1:50-200
Enzyme-linked Immunosorbent Assay: 1:100-200
Western Blot (WB) of anti-CILP antibody
Western Blot: Sample: Recombinant protein.

Immunohistochemistry (IHC) of anti-CILP antibody
DAB staining on fromalin fixed paraffin-embedded Brain tissue)

NCBI/Uniprot data below describe general gene information for CILP. It may not necessarily be applicable to this product.
NCBI Accession #
NP_775561.1
[Other Products]
NCBI GenBank Nucleotide #
NM_173385.2
[Other Products]
UniProt Primary Accession #
Q66K08
[Other Products]
UniProt Secondary Accession #
Q7TSS0; Q7TSS1; Q8BV01[Other Products]
UniProt Related Accession #
Q66K08[Other Products]
Molecular Weight
132,334 Da
NCBI Official Full Name
cartilage intermediate layer protein 1
NCBI Official Synonym Full Names
cartilage intermediate layer protein, nucleotide pyrophosphohydrolase
NCBI Official Symbol
Cilp??[Similar Products]
NCBI Official Synonym Symbols
9830114D16; C130036G17Rik
??[Similar Products]
NCBI Protein Information
cartilage intermediate layer protein 1
UniProt Protein Name
Cartilage intermediate layer protein 1
Protein Family
Cartilage intermediate layer protein
UniProt Gene Name
Cilp??[Similar Products]
UniProt Synonym Gene Names
CILP-1??[Similar Products]
UniProt Comments for CILP
CILP: Probably plays a role in cartilage scaffolding. May act by antagonizing TGF-beta1 (TGFB1) and IGF1 functions. Has the ability to suppress IGF1-induced proliferation and sulfated proteoglycan synthesis, and inhibits ligand-induced IGF1R autophosphorylation. May inhibit TGFB1-mediated induction of cartilage matrix genes via its interaction with TGFB1. Overexpression may lead to impair chondrocyte growth and matrix repair and indirectly promote inorganic pyrophosphate (PPi) supersaturation in aging and osteoarthritis cartilage. Defects in CILP are a cause of susceptibility to intervertebral disk disease (IDD). A common musculo- skeletal disorder caused by degeneration of intervertebral disks of the lumbar spine. It results in low-back pain and unilateral leg pain. Susceptibility to intervertebral disk disease, is conferred by variant p.Ile395Thr (PubMed:15864306).
Protein type: Motility/polarity/chemotaxis; Secreted; Secreted, signal peptide
Chromosomal Location of Human Ortholog: 9|9 C
Cellular Component: extracellular matrix; extracellular region; extracellular space; proteinaceous extracellular matrix
Biological Process: negative regulation of insulin-like growth factor receptor signaling pathway
Research Articles on CILP
1. Overexpression of CILP in the nucleus pulposus cells promotes disc degeneration, indicating that CILP plays a direct role in the pathogenesis of lumbar disc disease.
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.